GeneDx Holdings (WGS) Current Leases (2020 - 2021)
GeneDx Holdings' (WGS) quarterly Current Leases came in at $3.4 million in Q4 2021, down 2.48% year-over-year from $3.5 million in Q4 2020, and down 2.48% quarter-over-quarter from $3.5 million in Q4 2020.
Powered by 
Analysis
GeneDx Holdings (WGS) Current Leases (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Current Leases for 2 consecutive years, with $3.4 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Current Leases fell 2.48% year-over-year to $3.4 million in Q4 2021; TTM through Dec 2021 was $3.4 million, a 2.48% decrease from a year earlier, with the FY2021 full-year figure at $3.4 million, down 2.48% from the prior year.
- Current Leases was $3.4 million for Q4 2021 at GeneDx Holdings, down from $3.5 million in the prior quarter.
- Over five years, Current Leases peaked at $3.5 million in Q4 2020 and troughed at $3.4 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 180.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 180.30 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 12.19 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 5.47 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 6.34 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 8.82 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | - |